NCT00002869View on ClinicalTrials.gov

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

PHASE3UnknownINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 1995

Conditions
Leukemia
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

cytarabine

DRUG

hydroxyurea

Trial Locations (1)

EH4 2XU

Western General Hospital, Edinburgh

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV